Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · IEX Real-Time Price · USD
2.800
-0.130 (-4.44%)
At close: Jul 19, 2024, 4:00 PM
2.790
-0.010 (-0.36%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $14.60 million as of July 22, 2024. Its market cap has decreased by -50.50% in one year.
Market Cap
14.60M
Enterprise Value
19.89M
1-Year Change
-50.50%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $14.60M, a decrease of -92.39%. That is a compound annual growth rate of -52.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 10.60M | -44.21% |
| Dec 29, 2023 | 19.00M | -53.88% |
| Dec 30, 2022 | 41.20M | -51.47% |
| Dec 31, 2021 | 84.90M | -55.78% |
| Feb 5, 2021 | 191.99M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galecto | 15.07M |
| Centogene | 15.07M |
| Immuron | 15.05M |
| Talphera | 14.78M |
| Star Equity Holdings | 14.64M |
| BriaCell Therapeutics | 14.44M |
| Flora Growth | 14.44M |
| XTL Biopharmaceuticals | 14.00M |